Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Immunomedics Inc

+ Add to Watchlist

IMMU:US

4.1200 USD 0.0100 0.24%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Immunomedics Inc (IMMU)

Open: 4.1000 Day's Range: 4.0700 - 4.1600 Volume: 616,384
Previous Close: 4.1300 52wk Range: 3.0400 - 5.4800 1-Yr Rtn: +4.04%

Stock Chart for IMMU

No chart data available.
  • IMMU:US 4.1200
  • 1D
  • 1M
  • 1Y
4.1300
Interactive IMMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMMU

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4900
Est. EPS (USD) (06/2015) -0.5200
Est. PEG Ratio -
Market Cap (M USD) 384.76
Shares Outstanding (M) 93.39
30 Day Average Volume 699,102
Price/Book (mrq) 23.1196
Price/Sale (ttm) 83.3089
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0010
Dividend Ex-Date 03/15/2002
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMMU

Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.

David M GoldenbergChairman/FounderCynthia L SullivanPresident/CEO
Francois E WilhelmChief Medical OfficerPeter P PfreundschuhVP:Finance/CFO
More Company Profile & Key Executives for IMMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil